NCI center for cancer research (CCR) office of information technology (OIT) support services
Active Awarded Last action
- Contract number
- 75N91025F00078
- Awardee
-
Corelogix Asclepius JV, LLC UEI VSLJHMU2WNM1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,425,319
Award facts
- Contract value 92% obligated
-
- $3,425,319.46 Current, with exercised options
- $3,714,667.01 Potential, with all options
- Completion date 57% complete
- Current and potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,876,271 | |
| Other Administrative Action | $0 | |
| Original award | $1,549,048 |
About this award
The National Cancer Institute issued a delivery order to Corelogix Asclepius JV, LLC on September 4, 2025, under the 8(a) STARS III GWAC for National Cancer Institute Center for Cancer Research Office of Information Technology support services, with a ceiling value of $3,714,667.01.
The 8(a) STARS III is a $50 billion GSA-administered multiple-award GWAC for IT services issued to 8(a)-certified small disadvantaged businesses, supporting performance-based, fixed-price, time-and-materials, and labor-hour task orders across civilian federal agencies. Place of performance is Rockville, MD. The order extends through September 3, 2027, and is priced on a labor-hour basis. Corelogix Asclepius JV, LLC is an SBA-certified 8(a) small disadvantaged business joint venture. This delivery order was issued under the competitive 8(a) set-aside.
Quick answers
Who was awarded contract 75N91025F00078?
75N91025F00078 was awarded to Corelogix Asclepius JV, LLC by National Cancer Institute (National Institutes of Health) on September 4, 2025.
How much is contract 75N91025F00078 worth?
The government has obligated $3,425,319 on 75N91025F00078. Its potential value, with all options, is $3,714,667.
Is contract 75N91025F00078 an order under another contract?
Yes. 75N91025F00078 is a delivery order under 47QTCB21D0139, a government wide acquisition contract (GWAC), on 8(a) STARS III (STARS III).
Was contract 75N91025F00078 competed?
The extent of competition for 75N91025F00078 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award